Stay updated with breaking news from Given Cytek Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 43 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Cytek Biosciences to similar businesses based on the strength of its institutional ownership, earnings, analyst recommendations, valuation, risk, profitability and dividends. Analyst Ratings This is […]
Cytek Biosciences (NASDAQ:CTKB – Get Rating) and Bio-Rad Laboratories (NYSE:BIO.B – Get Rating) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, risk, profitability, analyst recommendations and valuation. Analyst Ratings This is a summary of recent ratings for […]
Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it contrast to its competitors? We will compare Cytek Biosciences to related businesses based on the strength of its valuation, institutional ownership, risk, profitability, dividends, analyst recommendations and earnings. Institutional & Insider Ownership 36.0% of […]
Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Cytek Biosciences to related businesses based on the strength of its analyst recommendations, dividends, institutional ownership, profitability, earnings, risk and valuation. Profitability This table compares […]
Cytek Biosciences (NASDAQ:CTKB – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its peers? We will compare Cytek Biosciences to related businesses based on the strength of its earnings, valuation, dividends, institutional ownership, analyst recommendations, risk and profitability. Earnings & Valuation This […]